Cite
HARVARD Citation
Murgia, V. et al. (2010). Multicenter Phase 2 Study of Combined Gemcitabine and Epirubicin as Second-Line Treatment for Patients With Advanced Ovarian Cancer. International journal of gynecological cancer. 20 (6), pp. 953-957. [Online].